The impact of chronic obstructive pulmonary disease in patients hospitalized for worsening heart failure with reduced ejection fraction: An analysis of the EVEREST trial

Journal of Cardiac Failure

Volumn 18, Issue 7, 2012, Pages 515-523

  Mentz, Robert J ^a   Schmidt, Philip H ^b   Kwasny, Mary J ^b   Ambrosy, Andrew P ^c   O'Connor, Christopher M ^b   Konstam, Marvin A ^d   Zannad, Faiez ^e   Maggioni, Aldo P ^f   Swedberg, Karl ^g   Gheorghiade, Mihai ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e Centre d'Investigations Cliniques   (France)

^f ANMCO RESEARCH CENTER   (Italy)

^g UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

COPD; heart failure; hospitalization; outcomes

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; HYDRALAZINE; INOTROPIC AGENT; NITRATE; STEROID; THEOPHYLLINE;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; DISEASE EXACERBATION; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MALE; MORTALITY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK REDUCTION; SYSTOLIC DYSFUNCTION; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; ALDOSTERONE ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COMORBIDITY; FEMALE; HEART FAILURE, SYSTOLIC; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STROKE VOLUME;

EID: 84862994170     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2012.04.010     Document Type: Article

References (41)

1. D. Lloyd-Jones, R.J. Adams, T.M. Brown, M. Carnethon, S. Dai, and G. De Simone Heart disease and stroke statistics - 2010 update: a report from the American Heart Association Circulation 121 2010 e46 e215
2. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, and P.A. Poole-Wilson ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
3. C.M. O'Connor, W.T. Abraham, N.M. Albert, R. Clare, W. Gattis Stough, and M. Gheorghiade Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) Am Heart J 156 2008 662 673
4. C.M. O'Connor, A.B. Miller, J.E. Blair, M.A. Konstam, P. Wedge, and M.C. Bahit Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program Am Heart J 159 2010 841 849 e1
5. P.S. Pang, M. Komajda, and M. Gheorghiade The current and future management of acute heart failure syndromes Eur Heart J 31 2010 784 793
6. D.T. Ko, J.V. Tu, F.A. Masoudi, Y. Wang, E.P. Havranek, and S.S. Rathore Quality of care and outcomes of older patients with heart failure hospitalized in the United States and Canada Arch Intern Med 165 2005 2486 2492 (Pubitemid 41720010)
7. F. Gustafsson, C. Torp-Pedersen, H. Burchardt, P. Buch, M. Seibaek, and E. Kjoller Female sex is associated with a better long-term survival in patients hospitalized with congestive heart failure Eur Heart J 25 2004 129 135 (Pubitemid 38112151)
8. P.A. McCullough, J.E. Hollander, R.M. Nowak, A.B. Storrow, P. Duc, and T. Omland Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department Acad Emerg Med 10 2003 198 204 (Pubitemid 36292619)
9. H. Ni, D.J. Nauman, and R.E. Hershberger Managed care and outcomes of hospitalization among elderly patients with congestive heart failure Arch Intern Med 158 1998 1231 1236 (Pubitemid 28252487)
10. A. Macchia, S. Monte, M. Romero, A. D'Ettorre, and G. Tognoni The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure Eur J Heart Failure 9 2007 942 948 (Pubitemid 47332320)
11. L. Staszewsky, M. Wong, S. Masson, S. Barlera, E. Carretta, and A.P. Maggioni Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial J Cardiac Failure 13 2007 797 804 (Pubitemid 350214524)
12. R.J. Mentz, M. Fiuzat, D.M. Wojdyla, K. Chiswell, M. Gheorghiade, and G.C. Fonarow Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF Eur J Heart Failure 14 2012 395 403
13. M. Gheorghiade, C. Orlandi, J.C. Burnett, D. Demets, L. Grinfeld, and A. Maggioni Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) J Cardiac Failure 11 2005 260 269 (Pubitemid 40626781)
14. M.A. Konstam, M. Gheorghiade, J.C. Burnett Jr., L. Grinfeld, A.P. Maggioni, and K. Swedberg Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial JAMA 297 2007 1319 1331 (Pubitemid 46513233)
15. J.B. Braunstein, G.F. Anderson, G. Gerstenblith, W. Weller, M. Niefeld, and R. Herbert Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure J Am Coll Cardiol 42 2003 1226 1233 (Pubitemid 37188347)
16. H. Quan, V. Sundararajan, P. Halfon, A. Fong, B. Burnand, and J.C. Luthi Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data Med Care 43 2005 1130 1139 (Pubitemid 41587600)
17. R.W. Light, and R.B. George Serial pulmonary function in patients with acute heart failure Arch Intern Medic 143 1983 429 433 (Pubitemid 13156428)
18. C.C. Naum, F.C. Sciurba, and R.M. Rogers Pulmonary function abnormalities in chronic severe cardiomyopathy preceding cardiac transplantation Am Rev Respir Dis 145 1992 1334 1338
19. J.G. Cleland, K. Swedberg, F. Follath, M. Komajda, A. Cohen-Solal, and J.C. Aguilar The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis Eur Heart J 24 2003 442 463 (Pubitemid 36286187)
20. P.M. Calverley, J.A. Anderson, B. Celli, G.T. Ferguson, C. Jenkins, and P.W. Jones Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med 356 2007 775 789 (Pubitemid 46294610)
21. D.P. Tashkin, B. Celli, S. Senn, D. Burkhart, S. Kesten, and S. Menjoge A 4-year trial of tiotropium in chronic obstructive pulmonary disease N Engl J Med 359 2008 1543 1554
22. C.T. Lien, N.D. Gillespie, A.D. Struthers, and M.E. McMurdo Heart failure in frail elderly patients: diagnostic difficulties, co-morbidities, polypharmacy and treatment dilemmas Eur J Heart Failure 4 2002 91 98 (Pubitemid 34113333)
23. M.H. van der Wal, T. Jaarsma, and D.J. van Veldhuisen Non-compliance in patients with heart failure; how can we manage it? Eur J Heart Failure 7 2005 5 17 (Pubitemid 40092486)
24. S. Salpeter, T. Ormiston, and E. Salpeter Cardioselective beta-blockers for chronic obstructive pulmonary disease Cochrane Database Syst Rev 2005 CD003566
25. S.A. Hunt, W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, and T.G. Ganiats 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
26. J. Lindenfeld, N.M. Albert, J.P. Boehmer, S.P. Collins, J.A. Ezekowitz, and M.M. Givertz HFSA 2010 Comprehensive Heart Failure Practice Guideline J Cardiac Failure 16 2010 e1 e194
27. A. Jones, and D.R. Woods Skeletal muscle RAS and exercise performance Intl J Biochem Cell Biology 35 2003 855 866 (Pubitemid 36379327)
28. S.D. Anker, A. Negassa, A.J. Coats, R. Afzal, P.A. Poole-Wilson, and J.N. Cohn Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study Lancet 361 2003 1077 1083 (Pubitemid 36369559)
29. C. Coirault, A. Hagege, D. Chemla, M.D. Fratacci, C. Guerot, and Y. Lecarpentier Angiotensin-converting enzyme inhibitor therapy improves respiratory muscle strength in patients with heart failure Chest 119 2001 1755 1760 (Pubitemid 32744933)
30. G.B. Mancini The 'double dip' hypothesis: simultaneous prevention of cardiovascular and pulmonary morbidity and mortality using angiotensin II type 1 receptor blockers Can J Cardiol 21 2005 519 523 (Pubitemid 40823605)
31. K. Kuba, Y. Imai, and J.M. Penninger Angiotensin-converting enzyme 2 in lung diseases Curr Opin Pharmacol 6 2006 271 276 (Pubitemid 43670913)
32. T.H. Le Jemtel, M. Padeletti, and S. Jelic Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure J Am Coll Cardiol 49 2007 171 180 (Pubitemid 46054390)
33. I. Mahe, O. Chassany, A.S. Grenard, C. Caulin, and J.F. Bergmann Defining the role of calcium channel antagonists in heart failure due to systolic dysfunction Am J Cardiovasc Drugs 3 2003 33 41 (Pubitemid 36240413)
34. D.H. Au, R.N. Lemaitre, J.R. Curtis, N.L. Smith, and B.M. Psaty The risk of myocardial infarction associated with inhaled beta-adrenoceptor agonists Am J Respir Crit Care Med 161 2000 827 830 (Pubitemid 30171738)
35. S.R. Salpeter, T.M. Ormiston, and E.E. Salpeter Cardiovascular Effects of β-agonists in patients with asthma and COPD Chest 125 2004 2309 2321 (Pubitemid 38796452)
36. S. Singh, Y.K. Loke, and C.D. Furberg Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis JAMA 300 2008 1439 1450
37. D.H. Au, E.M. Udris, V.S. Fan, J.R. Curtis, M.B. McDonell, and S.D. Fihn Risk of mortality and heart failure exacerbations associated with inhaled β-adrenoceptor agonists among patients with known left ventricular systolic dysfunction Chest 123 2003 1964 1969 (Pubitemid 36706719)
38. D.D. Sin, and S.F. Man Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality Proc Am Thorac Soc 2 2005 8 11 (Pubitemid 40562956)
39. D.S. Lee, P.C. Austin, J.L. Rouleau, P.P. Liu, D. Naimark, and J.V. Tu Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model JAMA 290 2003 2581 2587 (Pubitemid 37443288)
40. P. Jong, E. Vowinckel, P.P. Liu, Y. Gong, and J.V. Tu Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study Arch Intern Med 162 2002 1689 1694
41. D. Rusinaru, I. Saaidi, S. Godard, H. Mahjoub, C. Battle, and C. Tribouilloy Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure Am J Cardiol 101 2008 353 358 (Pubitemid 351162971)